Back3D Medicines Overview

3D Medicines Receivables

3D Medicines's receivables is $62M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$62.12M
↓ 35.04% YoYΔ $-33.51M vs prior year quarter

Peer trimmed avg / median

Loading

3D Medicines Receivables History

Loading

3D Medicines vs. peers: Receivables Comparison

Loading

3D Medicines Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

3D Medicines (1244.HK) FAQ

As of the most recent data (June 2026), 1244.HK shows a receivables of $62M. That compares with $96M in the prior-year period — down 35.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 1244.HK's receivables is now $62M (was $96M) — a 35.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether 3D Medicines is outperforming or lagging.

Tracking 1244.HK's receivables over time shows whether 3D Medicines is scaling, shrinking, or reshaping that part of the business. The current reading is $62M That compares with $96M in the prior-year period — down 35.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has 3D Medicines's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $62M) with ownership activity and broader fundamentals.

3D Medicines's receivables is $62M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.